Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.

Ilse A C SpiekmanBirgit S GeurtsLaurien J ZeverijnGijs F de WitVincent van den Noort Paul Roepman Wendy W J de Leng Anne M L JansenBenno KustersLaurens V Beerepoot Filip Yves Francine De Vos Derk-Jan A de Groot Jan Willem B de Groot Ann Hoeben Jan Buter André B P van Kuilenburg Emile E VoestHenk M W Verheul

Published in: The oncologist (2024)

Panitumumab treatment provides limited CB in patients with recurrent RAF/RASwt glioblastoma precluding further development of this therapeutic strategy.

Keyphrases

wild type
randomized controlled trial
emergency department
adverse drug
electronic health record